ClinicalTrialsFinder

Resectable MMR-deficient Solid Tumors Clinical Trials in Amsterdam, North Holland

1 recruitingAmsterdam, North Holland, Netherlands

Showing 1–1 of 1 trials

Recruiting
Phase 2Phase 3

Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations

Resectable MMR-deficient Solid TumorsResectable MMR-proficient Solid Tumors
The Netherlands Cancer Institute133 enrolled1 locationNCT06279130